Genesco Inc
GCO NYSEΒ· Retail-Shoe Stores
Last close Β· Oct 26, 2026
$36.35
KIRA Β· Stoqlyβs AI analyst, in plain words
- Genesco Inc had $2.4B of revenue in fiscal 2026, up 4.8% on the year before. Over five years, revenue changed +6.4% a year on average.
- Its operating margin was 0.7%, up 0.1Β pts: of every 100 in sales, about 1 is left after running the business.
- Genesco Inc made $13.3M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew β13.9% a year.
- Free cash flow was $83.7M in fiscal 2026, 3.4% of revenue.
- Genesco Inc returned $12.6M to shareholders in fiscal 2026, 15% of free cash flow. The diluted share count fell 2.0%.
- Genesco Inc has $102M more cash than debt.
Market cap
$397M
P/E
9.2x
Revenue
$2.4B
Net income
$13.3M
Free cash flow
$83.7M
Operating margin
0.7%
Genesco Inc in 30 seconds Β· fiscal 2026
Are sales growing?
+4.8%
Only a little. Sales grew 4.8% last year.
Does it make a profit?
0.5%
A little. It keeps 0.5% of every sale as profit.
Does profit turn into cash?
3.4%
Partly. 3.4% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
7 / 9
Solid. It passes 7 of 9 health tests.
How is the share priced?
9.2x
One share costs 9.2 times its yearly profit per share.
What Genesco Inc does
No business description yet.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K Β· Mar 25, 2026
- Legal name
- GENESCO INC
- CIK
- 0000018498
Genesco Inc Β· GCO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.4B | $2.4B | $2.3B | $2.3B | $2.4B |
| Revenue growth | 35.6% | β1.5% | β2.5% | 0.0% | 4.8% |
| Net interest income | β$2.4M | β$2.9M | β$7.8M | β$4.3M | β$4.1M |
| Gross margin | 48.8% | 47.6% | 47.3% | 47.2% | 46.3% |
| Operating margin | 6.4% | 3.9% | β0.6% | 0.6% | 0.7% |
| Net income | $115M | $71.9M | β$16.8M | β$18.9M | $13.3M |
| Net margin | 4.7% | 3.0% | β0.7% | β0.8% | 0.5% |
| Diluted EPS | $7.92 | $5.66 | β$1.50 | β$1.74 | $1.25 |
| Cash | |||||
| Cash from operations | $240M | β$165M | $94.8M | $87.9M | $146M |
| Capital expenditure | $53.9M | $59.9M | $60.3M | $41.1M | $62.1M |
| Free cash flow | $186M | β$225M | $34.5M | $46.8M | $83.7M |
| FCF margin | 7.7% | β9.4% | 1.5% | 2.0% | 3.4% |
| Share buybacks | $78.1M | $77.5M | $32.0M | $9.8M | $12.6M |
| Share count change | 2.1% | β12.4% | β11.5% | β3.6% | β2.0% |
| Debt and strength | |||||
| Cash and short-term investments | $321M | $48.0M | $35.2M | $34.0M | $105M |
| Debt incl. finance leases | $15.7M | $44.9M | $34.7M | $0.0M | $3.4M |
| Shareholders' equity | $602M | $607M | $571M | $547M | $567M |
| Net debt / EBITDA | β1.5x | β0.0x | β0.0x | β0.5x | β1.4x |
| Current ratio | 1.6x | 1.6x | 1.6x | 1.6x | 1.6x |
| Interest coverage | 63.5x | 31.9x | β1.7x | β | β |
| Returns and quality | |||||
| Return on capital | 39.3% | 12.4% | β1.9% | 1.8% | 3.7% |
| Return on equity | 19.6% | 11.9% | β2.9% | β3.4% | 2.4% |
| Return on tangible equity | 21.5% | 13.3% | β3.1% | β3.7% | 2.5% |
| Piotroski F-score | 7 | 3 | 6 | 5 | 7 |
| Altman Z'' | 3.2 | 2.9 | 2.4 | 2.6 | 2.6 |
Insiders bought, 12 months
$0.1M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Genesco Inc Β· GCO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $36.35 a share, the company is worth $397M: 9.2 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000018498). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
